• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】12511

【品名】3-(1H-1,2,3,4-Tetraazol-5-yl)aniline; 3-(1H-1,2,3,4-Tetraazol-5-yl)phenylamine

【CA登记号】

【 分 子 式 】C7H7N5

【 分 子 量 】161.16628

【元素组成】C 52.17% H 4.38% N 43.45%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(I)

By condensation of 3-(5-tetrazolyl)aniline (I) with oxalic acid monochloride butyl ester (II) in cool pyridine.

1 Goto, H. (Wakamoto Pharmaceutical Co., Ltd.); Aminophenyltetrazole derivative and salt thereof. JP 1982011975 .
2 Chu, S.S.; Tazanolast. Drugs Fut 1988, 13, 11, 968.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12511 3-(1H-1,2,3,4-Tetraazol-5-yl)aniline; 3-(1H-1,2,3,4-Tetraazol-5-yl)phenylamine C7H7N5 详情 详情
(II) 23246 2-butoxy-2-oxoacetyl chloride C6H9ClO3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

Acitazanolast can be obtained by two related procedures: 1) By condensation of 3-(1H-tetrazol-5-yl)aniline (I) with oxalyl chloride (II) in dimethoxyethane. 2) By condensation of the aniline (I) with ethyl oxalyl chloride (III) by means of triethylamine in DMF to the corresponding ethyl ester (IV), which is then hydrolyzed with base (KOH or NaOH) in ethanol.

1 Rabasseda, X.; Mealy, N.; Castaner, J.; Acitazanolast. Drugs Fut 1995, 20, 9, 873.
2 Sawaki, S.; Ootake, Y.; Hashimoto, T.; Abe, T.; Horio, Y. (Wakamoto Pharmaceutical Co., Ltd.); 3-(1H-Tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmacological compsns. Containing the cpd. EP 0256507; JP 1988044570; US 4795756 .
3 Sawaki, M.; Ohtake, Y.; Hashimoto, M.; Abe, T.; Horio, Y. (Wakamoto Pharmaceutical Co., Ltd.); Antiallergic agents. JP 1989029312 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12511 3-(1H-1,2,3,4-Tetraazol-5-yl)aniline; 3-(1H-1,2,3,4-Tetraazol-5-yl)phenylamine C7H7N5 详情 详情
(III) 11043 Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride 4755-77-5 C4H5ClO3 详情 详情
(IV) 12513 ethyl 2-oxo-2-[3-(1H-1,2,3,4-tetraazol-5-yl)anilino]acetate C11H11N5O3 详情 详情
Extended Information